A
M
Last name: ANDREANI
First name: Marine
No description
Alternative strategies targeting dysregulated cytokine balance could be considered for these patients at high risk of relapse.
Exciting times for the field of renal autoimmune diseases have begun. In 2021, for the first time, two new drugs belimumab (1) and voclosporin ( 2) are approved for the treatment of lupus nephritis (LN) (1, 2). Other novel targeted therapies demonstrate clinical efficacy in large, randomized trials, such as avacopan for ANCA-associated...
Alternative strategies targeting dysregulated cytokine balance could be considered for these patients at high risk of relapse.
International audience
Background and objectives Different rituximab protocols are used to treat membranous nephropathy. We compared two rituximab protocols in patients with membranous nephropathy. Design, setting, participants, & measurements Twenty-eight participants from the NICE cohort received two infusions of 1-g rituximab at 2-week intervals, whereas 27...